As of Oct 24
| -0.06 / -1.68%|
The 3 analysts offering 12-month price forecasts for BioTime Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +70.94% increase from the last price of 3.51.
The current consensus among 3 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.